Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study64

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study41

Views

Views
February 20251
March 202517
April 20253
May 20250
June 20252
July 202518
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
Brazil8
United States6
United Kingdom2
Canada1
Chile1
Spain1
Ethiopia1
Kenya1
Mexico1
 

Top cities views

Views
Awasa1
Camaquã1
Canoas1
Careaçu1
Ciudad del Este1
Concepción1
Contagem1
Council Bluffs1
Fairburn1
Festus1